Raphael Pharmaceutical Inc.
OTC: RAPH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Shlomo Pilo
- Headquarters
- Jaffa, Israel
- IPO year
- 2023
- Market cap
- $28.2M
- Website
- https://www.raphaelpharmaceutical.com
Loading RAPH…
Loading profile data…Frequently asked questions about RAPH
What does Raphael Pharmaceutical Inc. (RAPH) do?
Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating its efforts on discovering and clinically developing novel therapeutic solutions. These treatments primarily leverage cannabinoids and are designed to enhance patients' quality of life. Currently, the company's leading investigational drug candidate is being advanced...
Where does RAPH trade?
Raphael Pharmaceutical Inc. (RAPH) trades on the Other OTC.
What sector is RAPH in?
Raphael Pharmaceutical Inc. (RAPH) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Raphael Pharmaceutical Inc.?
Shlomo Pilo is the chief executive officer of Raphael Pharmaceutical Inc. (RAPH).
Where is Raphael Pharmaceutical Inc. headquartered?
Raphael Pharmaceutical Inc. is headquartered in Israel.
Does RAPH pay a dividend?
Raphael Pharmaceutical Inc. (RAPH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RAPH go public?
Raphael Pharmaceutical Inc. (RAPH) completed its initial public offering in 2023.